Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

Clinical trial NCT05823571 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05823571
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Acute Myelodysplastic Syndromes Myelomonocytic Leukemia, Chronic T-cell Prolymphocytic Leukemia CML Myeloproliferative Disorders Multiple Myeloma Plasma Cell Leukemia

Start date: 2023-07-06
Primary completion: 2028-03-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.